BDBM50238073 CHEMBL4066402

SMILES: C[C@@H](O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12

InChI Key: InChIKey=LDZDGXRDBZXTCD-OAHLLOKOSA-N

Data: 1 IC50  2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50238073   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
TGF-beta receptor type-1 (Homo sapiens (Human))	BDBM50238073 (CHEMBL4066402) Show SMILES C[C@@H](O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12 |r| Show InChI InChI=1S/C22H22FN5O/c1-13-4-5-17(23)16(8-13)20-9-19(14(2)10-25-20)27-18-6-7-24-21-11-26-28(22(18)21)12-15(3)29/h4-11,15,29H,12H2,1-3H3,(H,24,25,27)/t15-/m1/s1	PDB MMDB UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	7.90	n/a	n/a	n/a	n/a	n/a	n/a
Takeda California Curated by ChEMBL					Assay Description Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSI...				Bioorg Med Chem Lett 27: 1955-1961 (2017) Article DOI: 10.1016/j.bmcl.2017.03.026 BindingDB Entry DOI: 10.7270/Q2QJ7KKZ
					More data for this Ligand-Target Pair
TGF-beta receptor type-1 (Homo sapiens (Human))	BDBM50238073 (CHEMBL4066402) Show SMILES C[C@@H](O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12 |r| Show InChI InChI=1S/C22H22FN5O/c1-13-4-5-17(23)16(8-13)20-9-19(14(2)10-25-20)27-18-6-7-24-21-11-26-28(22(18)21)12-15(3)29/h4-11,15,29H,12H2,1-3H3,(H,24,25,27)/t15-/m1/s1	PDB MMDB UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	501	n/a	n/a	n/a	n/a
Takeda California Curated by ChEMBL					Assay Description Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation				Bioorg Med Chem Lett 27: 1955-1961 (2017) Article DOI: 10.1016/j.bmcl.2017.03.026 BindingDB Entry DOI: 10.7270/Q2QJ7KKZ
					More data for this Ligand-Target Pair
TGF-beta receptor type-1 (Homo sapiens (Human))	BDBM50238073 (CHEMBL4066402) Show SMILES C[C@@H](O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12 |r| Show InChI InChI=1S/C22H22FN5O/c1-13-4-5-17(23)16(8-13)20-9-19(14(2)10-25-20)27-18-6-7-24-21-11-26-28(22(18)21)12-15(3)29/h4-11,15,29H,12H2,1-3H3,(H,24,25,27)/t15-/m1/s1	PDB MMDB UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	100	n/a	n/a	n/a	n/a
Takeda California Curated by ChEMBL					Assay Description Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lacta...				Bioorg Med Chem Lett 27: 1955-1961 (2017) Article DOI: 10.1016/j.bmcl.2017.03.026 BindingDB Entry DOI: 10.7270/Q2QJ7KKZ
					More data for this Ligand-Target Pair